H-Index
38
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

MSMbanner
Medical Science Monitor Basic Research

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Get your full text copy in PDF

Post-TransplanIt Immune Serological Markers May Be Predictive of Chronic Rejection

Ronald H Kerman

Ann Transplant 2000; 5(2): 24-28

ID: 497522


Chronic rejection isan important cause ofgraft dysfunction and loss after the first posttransplant year [1].Two working hypotheses have evolved to explainthe etiology of the process. The first is an antigen-dependent phenomenon influenced by early immunological injury whereas the second is related to alloantigen-independent events contributing to progressive chronic graft dysfunction [2,3]. Our study, reported herein, focuses on the antigen-dependent aspects of chronic rejection. Several hypotheses have been proposed to explain the immunologic basis of chronic rejection. The first involvesrecurrent episodes of acute rejection that lead to protracted tissue damage and scarring [2,3].An alternative immune hypothesis to explain chronic rejection is that the immune-regulatory mechanisms that prevent acute rejection playa role in chronic rejection by supporting B cell responses and antibody formation. Therefore, chronic rejection may be a predominantly antibody- mediated form of graft damage..

Keywords: post-transplant antibody, chronic rejection

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree